Hypolipidemic effect of SR‑BI gene delivery by combining cationic liposomal microbubbles and ultrasound in hypercholesterolemic rats

Liu,Fang; Zhu,Jiaan; Huang,Yunxia; Guo,Wei; Rui,Mengjie; Xu,Yuhong; Hu,Bing

doi:10.3892/mmr.2013.1438

Hypolipidemic effect of SR‑BI gene delivery by combining cationic liposomal microbubbles and ultrasound in hypercholesterolemic rats

Authors:
- Fang Liu
- Jiaan Zhu
- Yunxia Huang
- Wei Guo
- Mengjie Rui
- Yuhong Xu
- Bing Hu
View Affiliations

Affiliations: Department of Ultrasound, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai Institute of Ultrasound in Medicine, Shanghai 200233, P.R. China, Pharmacy School of Shanghai Jiao Tong University, Shanghai 200233, P.R. China
Published online on: April 24, 2013 https://doi.org/10.3892/mmr.2013.1438
Pages: 1965-1969

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

High-density lipoprotein (HDL) is a key mediator in reverse cholesterol transport and is involved in a mechanism known as ‘selective lipid uptake’, a process mediated by scavenger receptor B type I (SR‑BI), which is a HDL receptor. The aim of the present study was to investigate the therapeutic effect of the SR‑BI gene when delivered by combining cationic liposomal microbubbles (CLMs) and ultrasound (US) in hypercholesterolemic rats. Hypercholesterolemia was induced by administration of excessive doses of vitamin D3 and cholesterol in rats. The CLMs consisted of perfluoropropane gas encapsulated in a phospholipid shell using the sonication‑lyophilization method. The SR‑BI gene, mixed with the self‑made microbubbles, was transfected into hypercholesterolemic rat arteries using therapeutic US. SR‑BI protein expression was determined by western blot analysis 2 days post-transfection. Two weeks after transfection, total cholesterol (TC), triglyceride (TG), low-density lipoprotein (LDL) and HDL serum concentrations were measured. Transfection efficiency of the SR‑BI gene in the SR‑BI + US/CLM group increased 6‑7‑fold compared with the SR‑BI group. Two weeks after transfection, plasma lipid levels in treated hypercholesterolemic rats were observed to be significantly reduced compared with rats that did not receive treatment. However, no significant change was observed in the SR‑BI group compared with that in the SR‑BI + US/CLM group. Results of the present study indicate that the combination of US and CLMs loaded with the SR‑BI gene may exert a protective role in hypercholesterolemia.

View Figures

View References

1	Suanarunsawat T, Devakul Na Ayutthaya W, Songsak T, Thirawarapan S and Poungshompoo S: Antioxidant activity and lipid-lowering effect of essential oils extracted from Ocimum sanctum L. leaves in rats fed with a high cholesterol diet. J Clin Biochem Nutr. 46:52–59. 2010. View Article : Google Scholar : PubMed/NCBI
2	Parthasarathy S, Barnett J and Fong LG: High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta. 1044:275–283. 1990. View Article : Google Scholar : PubMed/NCBI
3	Fielding CJ and Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res. 36:211–228. 1995.PubMed/NCBI
4	Oram JF and Yokoyama S: Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res. 37:2473–2491. 1996.PubMed/NCBI
5	Han J, Parsons M, Zhou X, Nicholson AC, Gotto AM Jr and Hajjar DP: Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104). Circulation. 110:3472–3479. 2004. View Article : Google Scholar : PubMed/NCBI
6	Hakkarainen T, Hemminki A, Curiel DT and Wahlfors J: A conditionally replicative adenovirus that codes for a TK-GFP fusion protein (Ad5Delta24TK-GFP) for evaluation of the potency of oncolytic virotherapy combined with molecular chemotherapy. Int J Mol Med. 18:751–759. 2006.
7	Iwamoto HS, Trapnell BC, McConnell CJ, Daugherty C and Whitsett JA: Pulmonary inflammation associated with repeated, prenatal exposure to an E1, E3-deleted adenoviral vector in sheep. Gene Ther. 6:98–106. 1999. View Article : Google Scholar : PubMed/NCBI
8	Taniyama Y, Tachibana K, Hiraoka K, et al: Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther. 9:372–380. 2002. View Article : Google Scholar : PubMed/NCBI
9	Taniyama Y, Tachibana K, Hiraoka K, et al: Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation. 105:1233–1239. 2002. View Article : Google Scholar : PubMed/NCBI
10	Christiansen JP, French BA, Klibanov AL, Kaul S and Lindner JR: Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol. 29:1759–1767. 2003. View Article : Google Scholar : PubMed/NCBI
11	Huang SL: Liposomes in ultrasonic drug and gene delivery. Adv Drug Deliv Rev. 60:1167–1176. 2008. View Article : Google Scholar : PubMed/NCBI
12	Suzuki R, Takizawa T, Negishi Y, et al: Gene delivery by combination of novel liposomal bubbles with perfluoropropane and ultrasound. J Control Release. 117:130–136. 2007. View Article : Google Scholar : PubMed/NCBI
13	Lindner JR: Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov. 3:527–532. 2004. View Article : Google Scholar : PubMed/NCBI
14	Li T, Tachibana K and Kuroki M and Kuroki M: Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison and Levovist in mice - initial results. Radiology. 229:423–428. 2003. View Article : Google Scholar : PubMed/NCBI
15	Ilies MA, Seitz WA and Balaban AT: Cationic lipids in gene delivery: principles, vector design and therapeutical applications. Curr Pharm Des. 8:2441–2473. 2002. View Article : Google Scholar : PubMed/NCBI
16	Hirko A, Tang F and Hughes JA: Cationic lipid vectors for plasmid DNA delivery. Curr Med Chem. 10:1185–1193. 2003. View Article : Google Scholar : PubMed/NCBI
17	Ritsch A, Tancevski I, Schgoer W, et al: Molecular characterization of rabbit scavenger receptor class B types I and II: portal to central vein gradient of expression in the liver. J Lipid Res. 45:214–222. 2004. View Article : Google Scholar : PubMed/NCBI
18	Wang W: Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 203:1–60. 2000. View Article : Google Scholar : PubMed/NCBI
19	Franks F: Freeze-drying of bioproducts: putting principles into practice. Eur J Pharm Biopharm. 45:221–229. 1998. View Article : Google Scholar : PubMed/NCBI
20	Molina MD, Armstrong TK, Zhang Y, Patel MM, Lentz YK and Anchordoquy TJ: The stability of lyophilized lipid/DNA complexes during prolonged storage. J Pharm Sci. 93:2259–2273. 2004. View Article : Google Scholar : PubMed/NCBI
21	del Pozo-Rodríguez A, Solinís MA, Gascón AR and Pedraz JL: Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy. Eur J Pharm Biopharm. 71:181–189. 2009.PubMed/NCBI
22	Kasper JC, Schaffert D, Ogris M, Wagner E and Friess W: Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability - A step closer from promising technology to application. J Control Release. 151:246–255. 2011. View Article : Google Scholar : PubMed/NCBI
23	Hsu JJ, Tintut Y and Demer LL: Vitamin D and osteogenic differentiation in the artery wall. Clin J Am Soc Nephrol. 3:1542–1547. 2008. View Article : Google Scholar : PubMed/NCBI
24	Hung CR, Chen WH and Wang PS: Protective effect of lysozyme chloride on gastric oxidative stress and hemorrhagic ulcers in severe atherosclerotic rats. Med Sci Monit. 13:BR271–BR279. 2007.PubMed/NCBI
25	Wu Y, Li J, Wang J, Si Q, Zhang J, Jiang Y and Chu L: Anti-atherogenic effects of centipede acidic protein in rats fed an atherogenic diet. J Ethnopharmacol. 122:509–516. 2009. View Article : Google Scholar : PubMed/NCBI
26	Wan CW, Wong CN, Pin WK, et al: Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-α in hypercholesterolemic rats induced with a high-cholesterol diet. Phytother Res. 2012:Jun 6–2012.(Epub ahead of print).
27	Hong SC, Zhao SP and Wu ZH: Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI) expression in the liver of hypercholesterolemic rabbits. Int J Cardiol. 115:29–35. 2007. View Article : Google Scholar : PubMed/NCBI
28	Acton S, Rigotti A, Landschulz KT, Xu S, Hobbs HH and Krieger M: Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271:518–520. 1996. View Article : Google Scholar : PubMed/NCBI
29	Hirano K, Yamashita S, Nakagawa Y, et al: Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. Circ Res. 85:108–116. 1999. View Article : Google Scholar
30	Trigatti BL, Krieger M and Rigotti A: Influence of the HDL receptor SR-BI on lipoprotein metabolism and atherosclerosis. Arterioscler Thromb Vasc Biol. 23:1732–1738. 2003. View Article : Google Scholar : PubMed/NCBI
31	Chinetti G, Gbaguidi FG, Griglio S, et al: CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation. 101:2411–2417. 2000. View Article : Google Scholar : PubMed/NCBI